Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-02-28 @ 3:53 AM
Study NCT ID:
NCT03072160
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2017-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: